标题 |
Phase III Results of a single oral and a 3-day IV/oral dosing regimen for the novel neurokinin-1 (NK1) receptor antagonist, casopitant: in the prevention of chemotherapy-induced nausea and vomiting (CINV) In patients receiving highly emetogenic chemotherapy (HEC)
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 |
期刊:Support Care Cancer 作者:Grunberg S, Russo M, Bandekar R, Wright O, Camlett I, Herrstedt J. 出版日期:2008 |
求助人 | |
下载 | 暂无链接,等待应助者上传 |